ACCUM Therapeutics' Reverse Merger Round

ACCUM Therapeutics raised a round of funding on July 28, 2017. Investors include Woden Venture Capital Corporation.

ACCUM Therapeutics is a biotechnology research and development company that aims to enhance the delivery of tumor-specific therapeutic drugs.…

Articles about ACCUM Therapeutics' Reverse Merger Round: